Heron Therapeutics
HRTX
HRTX
189 hedge funds and large institutions have $454M invested in Heron Therapeutics in 2024 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 67 increasing their positions, 39 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
189
Holders Change
+29
Holders Change %
+18.13%
% of All Funds
2.75%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
45
Increased
67
Reduced
39
Closed
15
Calls
$532K
Puts
$781K
Net Calls
-$249K
Net Calls Change
-$4.55M
Top Buyers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
$26.6M |
| 2 |
State Street
Boston,
Massachusetts
|
$18.5M |
| 3 |
Marshall Wace
London,
United Kingdom
|
$6.16M |
| 4 |
D.E. Shaw & Co
New York
|
$13.5M |
| 5 |
BlackRock
New York
|
$29.1M |
Top Sellers
| 1 |
O
OrbiMed
New York
|
$22.8M |
| 2 |
Millennium Management
New York
|
$5.02M |
| 3 |
CC
Clearline Capital
New York
|
$5.23M |
| 4 |
Renaissance Technologies
New York
|
$6.98M |
| 5 |
MAM
Monaco Asset Management
Monaco
|
$5.3M |
